Impact of a Mobile Geriatric Team With a Pharmacist on the Optimisation of Prescriptions in Elderly Inpatients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-19

Study Completion Date

2021-03-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In patients aged 75 years and older, polypathology is frequent and often associated with polypharmacy. This polypharmacy coupled with a lack of proactive elderly care can sometimes lead to hospitalisation. Due to comorbidities and complex problems, management of geriatric patients usually requires a multidisciplinary approach. In Toulouse University Hospital, elderly inpatients can benefit from a geriatric assessment by a Geriatric Mobile Team. Whether this team improve the prescriptions through the advice of a clinical pharmacist has not been demonstrated yet.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Collaborative Approach to Medication Reviews for Older Patients With Polypharmacy

NCT03909035

Medication Therapy Management

COMPLETED NA

Impact of Medication Reconciliation at Discharge on Potentially Inappropriate Medications in the Elderly : Community-hospital Coordination

NCT03415113

Hospital Geriatric

COMPLETED

Clinical and Economical Assessment of an Intervention to Reduce Potentially Inappropriate Medication in Polymedicated Elderly Patients

NCT02275572

Polypharmacy Elderly

COMPLETED NA

Therapeutic Optimization in Patients in Acute Geriatric Care at University Hospital of Montpellier

NCT04223921

Geriatrics Clinical Pharmacy

UNKNOWN

Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments

NCT03827031

Chronic Disease

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All participants will be identified via the geriatrician of the mobile geriatric team with the following inclusion criteria: age ≥ 75 years, ≥ 5 medications per day and being hospitalised either in emergency room, short-stay medicine unit or in a surgery department. For each patient, the pharmacist will detect potentially inappropriate prescribing (based on explicit criteria and an implicit approach) and liaise with the geriatrician for drug optimisations. The pharmaceutical advice will be added to the geriatrician's written report, and then addressed to the relevant physician. The implementation of the proposals will be evaluated immediately at the end of hospitalisation, and then reassessed three months later by calling the patient and/or his community pharmacist. A total of 250 patients will be enrolled over a 12 month-period. The evolution of potentially inappropriate prescribing will be assessed and their cost evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medication Therapy Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Medication therapy management

Medication therapy management by pharmacist-led medication review

Group Type EXPERIMENTAL

Medication therapy management

Intervention Type OTHER

The intervention is in the form of a pharmacist-led medication review aimed at detecting potentially inappropriate prescribing. It includes:

* Data collection on comorbidities, medication and laboratory results.
* A pharmacist's evaluation of the prescriptions based on the patient's conditions and on the current recommendations for clinical practice.
* A detailed feedback to the geriatrician.
* A written report addressed to the attending physician

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medication therapy management

The intervention is in the form of a pharmacist-led medication review aimed at detecting potentially inappropriate prescribing. It includes:

* Data collection on comorbidities, medication and laboratory results.
* A pharmacist's evaluation of the prescriptions based on the patient's conditions and on the current recommendations for clinical practice.
* A detailed feedback to the geriatrician.
* A written report addressed to the attending physician

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 75 or older
* Having 5 medications or more per day
* Being hospitalised either in emergency room, short-stay medicine unit or surgery department